XML 93 R80.htm IDEA: XBRL DOCUMENT v3.22.4
Note 16 - Non-controlling Interests - Summary of Income Statement Information (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Nov. 30, 2022
Aug. 31, 2022
Nov. 30, 2021
Aug. 31, 2021
Nov. 30, 2022
Nov. 30, 2021
Net (loss) income $ (61,635)   $ 5,797   $ (127,429) $ (28,807)
Other comprehensive (loss) income (42,240)   (48,672)   (105,057) (150,093)
Net comprehensive (loss) income (103,875) $ (128,611) (42,875) $ (136,025) (232,486) (178,900)
Comprehensive (loss) income attributable to NCI $ 7,311   $ (1,022)   11,150 6,023
Subsidiaries [Member]            
Revenue         65,545 53,237
Total expenses         88,769 27,003
Net (loss) income         (23,224) 26,234
Other comprehensive (loss) income         (12,548) (23,268)
Net comprehensive (loss) income         (35,772) 2,966
Comprehensive (loss) income attributable to NCI         5,094 6,023
Additional income attributable to NCI         6,056  
Net comprehensive (loss) income attributable to NCI         11,150  
Superhero Acquisition LP [Member]            
Revenue         0 0
Total expenses         (7,006) 0
Net (loss) income         7,006 0
Other comprehensive (loss) income         (11,321) (16,357)
Net comprehensive (loss) income         $ (4,315) $ (16,357)
Non-controlling interest % 32.00%   32.00%   32.00% 32.00%
Comprehensive (loss) income attributable to NCI         $ (1,381) $ (5,234)
Additional income attributable to NCI         0  
Net comprehensive (loss) income attributable to NCI         (1,381)  
CC Pharma Nordic ApS [Member]            
Revenue         108 136
Total expenses         471 178
Net (loss) income         (363) (42)
Other comprehensive (loss) income         0 26
Net comprehensive (loss) income         $ (363) $ (16)
Non-controlling interest % 25.00%   25.00%   25.00% 25.00%
Comprehensive (loss) income attributable to NCI         $ (91) $ (4)
Additional income attributable to NCI         0  
Net comprehensive (loss) income attributable to NCI         (91)  
Aphria Diamond [Member]            
Revenue         65,437 53,101
Total expenses         39,039 26,367
Net (loss) income         26,398 26,734
Other comprehensive (loss) income         (1,590) (2,817)
Net comprehensive (loss) income         $ 24,808 $ 23,917
Non-controlling interest % 49.00%   49.00%   49.00% 49.00%
Comprehensive (loss) income attributable to NCI         $ 12,156 $ 11,719
Additional income attributable to NCI         6,056  
Net comprehensive (loss) income attributable to NCI         18,212  
ColCanna S.A.S. [Member]            
Revenue         0 0
Total expenses         56,265 458
Net (loss) income         (56,265) (458)
Other comprehensive (loss) income         363 (4,120)
Net comprehensive (loss) income         $ (55,902) $ (4,578)
Non-controlling interest % 10.00%   10.00%   10.00% 10.00%
Comprehensive (loss) income attributable to NCI         $ (5,590) $ (458)
Additional income attributable to NCI         0  
Net comprehensive (loss) income attributable to NCI         $ (5,590)